Late-stage global biopharmaceutical company focused on developing and commercializing apitegromab for children and adults with spinal muscular atrophy (SMA) and other rare, severe, and debilitating neuromuscular diseases.
Scholar Rock is seeking an experienced Director of Vendor Quality Management to oversee vendors and service providers impacting GxP activities. The position will lead the implementation of a global risk-based GxP vendor oversight program and establish a vendor lifecycle management framework.
Late-stage global biopharmaceutical company focused on developing and commercializing apitegromab for children and adults with spinal muscular atrophy (SMA) and other rare, severe, and debilitating neuromuscular diseases.
Scholar Rock